323 related articles for article (PubMed ID: 26822362)
1. Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics.
Ubaldi M; Cannella N; Ciccocioppo R
Prog Brain Res; 2016; 224():251-84. PubMed ID: 26822362
[TBL] [Abstract][Full Text] [Related]
2. Neurobiological mechanisms in the transition from drug use to drug dependence.
Koob GF; Ahmed SH; Boutrel B; Chen SA; Kenny PJ; Markou A; O'Dell LE; Parsons LH; Sanna PP
Neurosci Biobehav Rev; 2004 Jan; 27(8):739-49. PubMed ID: 15019424
[TBL] [Abstract][Full Text] [Related]
3. Reinforcement principles for addiction medicine; from recreational drug use to psychiatric disorder.
Edwards S
Prog Brain Res; 2016; 223():63-76. PubMed ID: 26806771
[TBL] [Abstract][Full Text] [Related]
4. Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides.
Ubaldi M; Bifone A; Ciccocioppo R
Curr Opin Neurobiol; 2013 Aug; 23(4):684-91. PubMed ID: 23648086
[TBL] [Abstract][Full Text] [Related]
5. The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission.
Cannella N; Kallupi M; Ruggeri B; Ciccocioppo R; Ubaldi M
Prog Neurobiol; 2013 Jan; 100():48-59. PubMed ID: 23041581
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
7. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
Xu TR; Yang Y; Ward R; Gao L; Liu Y
Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptides and Addiction: An Introduction.
Thiele TE
Int Rev Neurobiol; 2017; 136():1-3. PubMed ID: 29056148
[TBL] [Abstract][Full Text] [Related]
9. [Role of hypothalamic orexin in drug addiction].
Han J; Li YH; Bai YJ; Sui N
Sheng Li Ke Xue Jin Zhan; 2007 Oct; 38(4):327-30. PubMed ID: 18232303
[TBL] [Abstract][Full Text] [Related]
10. Existing and Future Drugs for the Treatment of the Dark Side of Addiction.
Koob GF; Mason BJ
Annu Rev Pharmacol Toxicol; 2016; 56():299-322. PubMed ID: 26514207
[TBL] [Abstract][Full Text] [Related]
11. Drug addiction, dysregulation of reward, and allostasis.
Koob GF; Le Moal M
Neuropsychopharmacology; 2001 Feb; 24(2):97-129. PubMed ID: 11120394
[TBL] [Abstract][Full Text] [Related]
12. [Principles of the pharmacological treatment of drug addiction].
Saadan M; Scuvée-Moreau J; Seutin V
Rev Med Liege; 2013; 68(5-6):245-51. PubMed ID: 23888572
[TBL] [Abstract][Full Text] [Related]
13. Why is neuroimmunopharmacology crucial for the future of addiction research?
Hutchinson MR; Watkins LR
Neuropharmacology; 2014 Jan; 76 Pt B(0 0):218-27. PubMed ID: 23764149
[TBL] [Abstract][Full Text] [Related]
14. Chronic neuropharmacology of cocaine: progress in pharmacotherapy.
Gawin FH
J Clin Psychiatry; 1988 Feb; 49 Suppl():11-6. PubMed ID: 3276669
[TBL] [Abstract][Full Text] [Related]
15. Neuropharmacology of addiction and how it informs treatment.
Lingford-Hughes A; Watson B; Kalk N; Reid A
Br Med Bull; 2010; 96():93-110. PubMed ID: 21044987
[TBL] [Abstract][Full Text] [Related]
16. Neurocircuitry of alcohol addiction: synthesis from animal models.
Koob GF
Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
[TBL] [Abstract][Full Text] [Related]
17. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators.
Filip M; Frankowska M; Sadakierska-Chudy A; Suder A; Szumiec L; Mierzejewski P; Bienkowski P; Przegaliński E; Cryan JF
Neuropharmacology; 2015 Jan; 88():36-47. PubMed ID: 24971600
[TBL] [Abstract][Full Text] [Related]
18. [Current status in drug addiction and addiction memory research].
Wang HR; Gao XR; Zhang KG; Han JS
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):202-6. PubMed ID: 14628463
[TBL] [Abstract][Full Text] [Related]
19. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview.
Sanchis-Segura C; Spanagel R
Addict Biol; 2006 Mar; 11(1):2-38. PubMed ID: 16759333
[TBL] [Abstract][Full Text] [Related]
20. Behavioral reactivity and addiction: the adaptation of behavioral response to reward opportunities.
Trafton JA; Gifford EV
J Neuropsychiatry Clin Neurosci; 2008; 20(1):23-35. PubMed ID: 18305282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
